December 19, 2022—The European Society of Minimally Invasive Neurological Therapy (ESMINT) and EYMINT, its organization of young interventionists, are conducting a survey to obtain an overview of the use of any heparin in endovascular thrombectom…
Author: Endovascular Today - Latest News
RF Medical’s Mygen M-3004 and Myoblate Radiofrequency Ablation System Cleared by FDA
December 19, 2022—RF Medical Co., Ltd., a Korea-based manufacturer of thermal ablation systems, recently announced FDA clearance of the company’s Mygen M-3004 generator and Myoblate radiofrequency ablation system, which are now commercially…
Sonorous NV’s BossStent to Treat Symptomatic Cerebral Venous Diseases Used in First Patients in North America
December 16, 2022—Sonorous NV, Inc. announced that the company’s BossStent device, which is designed to treat patients with symptomatic cerebral venous diseases, was used in the first patients in North America.
The company will initiate …
Janssen’s Xarelto Studied for Secondary Prevention of VTE in Cancer Patients
December 15, 2022—The Janssen Pharmaceutical Companies of Johnson & Johnson recently announced observational data from 8 years of clinical practice showing that the company’s oral Factor Xa inhibitor Xarelto (rivaroxaban) is associated …
VentureMed’s FLEX First AV Registry Enrolls First Patient to Study Treatment of Arteriovenous Access Management
December 15, 2022—VentureMed Group, Inc. announced the commencement of enrollment in the FLEX First AV registry to evaluate arteriovenous (AV) access management with the company’s Flex Vessel Prep (VP) system. The Flex VP system has CE Mark…
Stryker’s Target Tetra Detachable Coil for Treating Small Aneurysms Cleared by FDA
December 15, 2022—Stryker announced FDA 510(k) clearance of the Target Tetra detachable coil, the latest addition to the company’s Target platform. The Target Tetra device, which is specifically designed to treat small aneurysms, combines a…
Corindus Rebranded as Siemens Healthineers Endovascular Robotics
December 14, 2022—Corindus, a Siemens Healthineers Company, announced it has been rebranded to Siemens Healthineers Endovascular Robotics, a dedicated business within the Advanced Therapies area of Siemens Healthineers. The aim of the Endovascula…
Access Vascular’s HydroPICC Dual-Lumen 5-F Catheter Used in First Patient
December 12, 2022—Access Vascular, Inc. (AVI) announced the first use of the company’s HydroPICC dual-lumen 5-F catheter, which is made from the company’s hydrophilic biomaterial featuring Mimix technology. In May 2022, AVI announced …
FDA Issues Revised Safety Communication Regarding Risk of Type III Endoleak and Endologix’s AFX AAA Graft System
December 6, 2022—The FDA issued an updated Safety Communication on the use of Endologix’s AFX Endovascular abdominal aortic aneurysm (AAA) graft systems. The new safety labeling is for the currently available AFX2 Endovascular AAA system an…
LimFlow Appoints Mike Mathias as Vice President, Commercial Operations
December 6, 2022—LimFlow SA, a France-based developer of minimally invasive technology for the treatment of chronic limb-threatening ischemia, announced the appointment of Mike Mathias as Vice President of Commercial Operations. The move comes as…